65 related articles for article (PubMed ID: 30590125)
1. Success of an International Learning Health Care System in Hematopoietic Cell Transplantation: The American Society of Blood and Marrow Transplantation Clinical Case Forum.
Barba P; Burns LJ; Litzow MR; Juckett MB; Komanduri KV; Lee SJ; Devlin SM; Costa LJ; Khan S; King A; Klein A; Krishnan A; Malone A; Mir M; Moravec C; Selby G; Roy V; Cochran M; Stricherz MK; Westmoreland MD; Perales MA; Wood WA
Biol Blood Marrow Transplant; 2016 Mar; 22(3):564-570. PubMed ID: 26718665
[TBL] [Abstract][Full Text] [Related]
2. Acute Lymphoblastic Leukemia with Central Nervous System Involvement-Challenges in Management.
Suryaprakash S; Inaba H
Indian J Pediatr; 2024 Jan; 91(1):59-66. PubMed ID: 37507619
[TBL] [Abstract][Full Text] [Related]
3. A five-gene signature may associate with central nervous system dissemination in adult acute lymphoblastic leukemia.
Sapienza MR; Chiaretti S; Cardinali D; Mazzara S; Chiarle R; Foà R; Pileri SA
Hematol Oncol; 2023 Oct; 41(4):789-791. PubMed ID: 37016899
[No Abstract] [Full Text] [Related]
4. ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells.
Lee DW; Santomasso BD; Locke FL; Ghobadi A; Turtle CJ; Brudno JN; Maus MV; Park JH; Mead E; Pavletic S; Go WY; Eldjerou L; Gardner RA; Frey N; Curran KJ; Peggs K; Pasquini M; DiPersio JF; van den Brink MRM; Komanduri KV; Grupp SA; Neelapu SS
Biol Blood Marrow Transplant; 2019 Apr; 25(4):625-638. PubMed ID: 30592986
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implications of cytogenetics in adults with acute lymphoblastic leukemia treated with inotuzumab ozogamicin.
Jabbour E; Advani AS; Stelljes M; Stock W; Liedtke M; Gökbuget N; Martinelli G; O'Brien S; White JL; Wang T; Luisa Paccagnella M; Sleight B; Vandendries E; DeAngelo DJ; Kantarjian HM
Am J Hematol; 2019 Apr; 94(4):408-416. PubMed ID: 30623490
[TBL] [Abstract][Full Text] [Related]
6. A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403.
Stock W; Luger SM; Advani AS; Yin J; Harvey RC; Mullighan CG; Willman CL; Fulton N; Laumann KM; Malnassy G; Paietta E; Parker E; Geyer S; Mrózek K; Bloomfield CD; Sanford B; Marcucci G; Liedtke M; Claxton DF; Foster MC; Bogart JA; Grecula JC; Appelbaum FR; Erba H; Litzow MR; Tallman MS; Stone RM; Larson RA
Blood; 2019 Apr; 133(14):1548-1559. PubMed ID: 30658992
[TBL] [Abstract][Full Text] [Related]
7. Combination Lenalidomide and Azacitidine: A Novel Salvage Therapy in Patients Who Relapse After Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia.
Craddock C; Slade D; De Santo C; Wheat R; Ferguson P; Hodgkinson A; Brock K; Cavenagh J; Ingram W; Dennis M; Malladi R; Siddique S; Mussai F; Yap C
J Clin Oncol; 2019 Mar; 37(7):580-588. PubMed ID: 30653424
[TBL] [Abstract][Full Text] [Related]
8. Advances in cellular and humoral immunotherapy - implications for the treatment of poor risk childhood, adolescent, and young adult B-cell non-Hodgkin lymphoma.
Chu Y; Gardenswartz A; Termuhlen AM; Cairo MS
Br J Haematol; 2019 Jun; 185(6):1055-1070. PubMed ID: 30613939
[TBL] [Abstract][Full Text] [Related]
9. Comparative outcomes of myeloablative and reduced-intensity conditioning allogeneic hematopoietic cell transplantation for therapy-related acute myeloid leukemia with prior solid tumor: A report from the acute leukemia working party of the European society for blood and bone marrow transplantation.
Lee CJ; Labopin M; Beelen D; Finke J; Blaise D; Ganser A; Itälä-Remes M; Chevallier P; Labussière-Wallet H; Maertens J; Yakoub-Agha I; Bourhis JH; Mailhol A; Mohty M; Savani BN; Nagler A
Am J Hematol; 2019 Apr; 94(4):431-438. PubMed ID: 30597620
[TBL] [Abstract][Full Text] [Related]
10. Involvement of the central nervous system in acute lymphoblastic leukemia: opinions on molecular mechanisms and clinical implications based on recent data.
Lenk L; Alsadeq A; Schewe DM
Cancer Metastasis Rev; 2020 Mar; 39(1):173-187. PubMed ID: 31970588
[TBL] [Abstract][Full Text] [Related]
11. Relapse Prevention with Tyrosine Kinase Inhibitors after Allogeneic Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblast Leukemia: A Systematic Review.
Warraich Z; Tenneti P; Thai T; Hubben A; Amin H; McBride A; Warraich S; Hannan A; Warraich F; Majhail N; Kalaycio M; Anwer F
Biol Blood Marrow Transplant; 2020 Mar; 26(3):e55-e64. PubMed ID: 31557532
[TBL] [Abstract][Full Text] [Related]
12. A prognostic score system in adult T-cell acute lymphoblastic leukemia after hematopoietic stem cell transplantation.
Xiao M; Zhou J; Zhu X; He Y; Wang F; Zhang Y; Mo X; Han W; Wang J; Wang Y; Chen H; Chen Y; Zhao X; Chang Y; Xu L; Liu K; Huang X; Zhang X
Bone Marrow Transplant; 2024 Apr; 59(4):496-504. PubMed ID: 38267585
[TBL] [Abstract][Full Text] [Related]
13. Novel strategies to prevent and overcome relapse after allogeneic hematopoietic cell transplantation in acute lymphoblastic leukemia.
Hodroj MH; Abou Dalle I; Moukalled N; El Cheikh J; Mohty M; Bazarbachi A
Front Immunol; 2023; 14():1191912. PubMed ID: 37359547
[TBL] [Abstract][Full Text] [Related]
14. How I prevent and treat central nervous system disease in adults with acute lymphoblastic leukemia.
Kopmar NE; Cassaday RD
Blood; 2023 Mar; 141(12):1379-1388. PubMed ID: 36548957
[TBL] [Abstract][Full Text] [Related]
15. Approach to the Adult Acute Lymphoblastic Leukemia Patient.
Sas V; Moisoiu V; Teodorescu P; Tranca S; Pop L; Iluta S; Pasca S; Blag C; Man S; Roman A; Constantinescu C; Rus I; Buse M; Fetica B; Marian M; Selicean C; Berindan-Neagoe I; Petrushev B; Bumbea H; Tanase A; Zdrenghea M; Fuji S; Kitano S; Tomuleasa C;
J Clin Med; 2019 Aug; 8(8):. PubMed ID: 31390838
[TBL] [Abstract][Full Text] [Related]
16. ASBMT Statement on Routine Prophylaxis for Central Nervous System Recurrence of Acute Lymphoblastic Leukemia following Allogeneic Hematopoietic Cell Transplantation.
Sauter CS; DeFilipp Z; Inamoto Y; Johnston L; Nagler A; Savani BN; Carpenter PA; Perales MA
Biol Blood Marrow Transplant; 2019 Mar; 25(3):e86-e88. PubMed ID: 30590125
[TBL] [Abstract][Full Text] [Related]
17. Use of intrathecal prophylaxis in allogeneic haematopoietic stem cell transplantation for malignant blood diseases: a survey of the European Group for Blood and Marrow Transplantation (EBMT).
Ruutu T; Corradini P; Gratwohl A; Holler E; Apperley J; Dini G; Rocha V; Schmitz N; Socié G; Niederwieser D
Bone Marrow Transplant; 2005 Jan; 35(2):121-4. PubMed ID: 15543201
[TBL] [Abstract][Full Text] [Related]
18. Central nervous system relapse in adults with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
Hamdi A; Mawad R; Bassett R; di Stasi A; Ferro R; Afrough A; Ram R; Dabaja B; Rondon G; Champlin R; Sandmaier BM; Doney K; Bar M; Kebriaei P
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1767-71. PubMed ID: 25017763
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
